Newest Immunotherapies for Blood Cancer! What to Know about Bispecifics & CAR T-Cell Therapy
Автор: The Patient Story
Загружено: 2022-10-14
Просмотров: 2035
Описание:
Cindy Chmielewski has been living with multiple myeloma for 14 years, she’s made researching the disease her passion, helping other patients. In this conversation, she joins top myeloma specialist, Dr. Saad Usmani, to discuss new immunotherapies for myeloma patients, breaking down CAR-T versus bispecific antibodies, looking at the pros and cons of each.
Special thanks to Janssen for its support of our patient program!
Full story & transcript → https://www.thepatientstory.com/patie...
The interview has only been edited for clarity.
Join Our Community:
Website : https://www.thepatientstory.com/
Facebook: @ThePatientStory
Instagram: @ThePatientStory
Twitter: @patient_story
______________________________
Contents of this video:
00:00 - Intro
01:01 - What is CAR T-cell therapy?
03:15 - Describe the side effects of CAR T-cell therapy
05:51 - Describe allogeneic CAR T-cell therapy
08:17 - CAR T-cell therapy targeting GPRC5D
09:27 - Breaking down bispecific antibodies
14:15 - What are TRIMM trials?
15:50 - CAR T-cell therapy for transplant-ineligible patients
18:33 - What will cure myeloma?
____________________________
#multiplemyeloma #myeloma #multiple_myeloma #cancercare #cancer #treatment #cancertreatment #cancerresearch #cancerpatient #clinicaltrial #thepatientstory #celltherapy
Повторяем попытку...
Доступные форматы для скачивания:
Скачать видео
-
Информация по загрузке:
